RxDoctor Payments Data

Bethany Hess

Family · Chicago, ILNPI 1811281348

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Gilead at 32.5% of the total. Reporting peaked in 2022 at $1,181 and has fallen 98.8% since, to $14 in 2025.

$2,976in general payments, 2019–2025

Across 171 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$967
  • Johnson & Johnson$676
  • Viiv Healthcare Company$476
  • Merck$303
  • Alkermes, Inc.$153
  • Janssen Products, LP$99
  • plus $303 from 10 others

What the payments were for

  • Food & beverage$2,87797%
  • Education$993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,976 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clonidine12$1,386

Paid to pharmacies, not to this prescriber.

Other family in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →